{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:56:57Z","timestamp":1792540617041,"version":"4.5.0"},"reference-count":245,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.phrs.2019.104458","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T11:34:52Z","timestamp":1568979292000},"page":"104458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Targeting BDNF signaling by natural products: Novel synaptic repair therapeutics for neurodegeneration and behavior disorders"],"prefix":"10.1016","volume":"148","author":[{"given":"Sweta","family":"Bawari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devesh","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Arg\u00fcelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana N.","family":"Sah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Fazel","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suowen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Anna","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Shirooie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2019.104458_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI200317522","article-title":"Neurodegeneration: what is it and where are we?","volume":"111","author":"Przedborski","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2019.104458_bib0010","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.jnen.0000228202.35163.c4","article-title":"Synaptic vulnerability in neurodegenerative disease","volume":"65","author":"Wishart","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.phrs.2019.104458_bib0015","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.3390\/ijms10062510","article-title":"Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders","volume":"10","author":"Choonara","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2019.104458_bib0020","first-page":"3","article-title":"New hopes and challenges for treatment of neurodegenerative disorders: great opportunities for young neuroscientists","volume":"4","author":"Kiaei","year":"2013","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0025","volume":"1549","author":"Goodman","year":"1996"},{"key":"10.1016\/j.phrs.2019.104458_bib0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.tpj.6500360","article-title":"Shedding light into the role of bdnf in the pharmacotherapy of Parkinson\u2019s disease","volume":"6","author":"Fumagalli","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.phrs.2019.104458_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-1-19","article-title":"Multiple pathways contribute to the pathogenesis of huntington disease","volume":"1","author":"Li","year":"2006","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phrs.2019.104458_bib0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/NMM:3:2:65","article-title":"Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders","volume":"3","author":"Mattson","year":"2003","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.phrs.2019.104458_bib0045","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"Spec No","key":"10.1016\/j.phrs.2019.104458_bib0050","doi-asserted-by":"crossref","first-page":"R182","DOI":"10.1093\/hmg\/ddl202","article-title":"Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease","volume":"15","author":"Talbot","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2019.104458_bib0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/mp.54.6.386","article-title":"Mechanisms of neurodegeneration in amyotrophic lateral sclerosis","volume":"54","author":"Cluskey","year":"2001","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.phrs.2019.104458_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1083\/jcb.201105092","article-title":"Cell biology of spinocerebellar Ataxia","volume":"197","author":"Orr","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2019.104458_bib0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/a902202c","article-title":"The influence of natural products upon drug discovery","volume":"17","author":"Newman","year":"2000","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.phrs.2019.104458_bib0070","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature03194","article-title":"Lessons from natural molecules","volume":"432","author":"Clardy","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104458_bib0075","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2019.104458_bib0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nchem.2479","article-title":"Counting on natural products for drug design","volume":"8","author":"Rodrigues","year":"2016","journal-title":"Nat. Chem."},{"key":"10.1016\/j.phrs.2019.104458_bib0085","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1002\/cpph.67","article-title":"Natural products as a foundation for drug discovery","volume":"86","author":"Beutler","year":"2009","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib0090","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1039\/c3np70052f","article-title":"Matching the power of high throughput screening to the chemical diversity of natural products","volume":"30","author":"Henrich","year":"2013","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.phrs.2019.104458_bib0095","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1039\/C8OB01388H","article-title":"Natural products as modulators of the Cyclic-AMP pathway: evaluation and synthesis of lead compounds","volume":"16","author":"Sengupta","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.phrs.2019.104458_bib0100","series-title":"Neurodegenerative Diseases: Unifying Principles","author":"Pillai","year":"2016"},{"key":"10.1016\/j.phrs.2019.104458_bib0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0005-2728(98)00114-5","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"1366","author":"Beal","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2019.104458_bib0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1017\/S1092852900024901","article-title":"Role of Mitochondria in Neurodegenerative Diseases: Mitochondria as a Therapeutic Target in Alzheimer\u2019s Disease","volume":"14","author":"Reddy","year":"2009","journal-title":"CNS Spectr."},{"key":"10.1016\/j.phrs.2019.104458_bib0115","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104458_bib0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneurol.2014.228","article-title":"Disturbed mitochondrial dynamics and neurodegenerative disorders","volume":"11","author":"Burte","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2019.104458_bib0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.112.192138","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"342","author":"Johri","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2019.104458_bib0130","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1007\/s11064-008-9855-x","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"33","author":"Schapira","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phrs.2019.104458_bib0135","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1212\/WNL.53.8.1787","article-title":"Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation","volume":"53","author":"Simon","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2019.104458_bib0140","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.282.5391.1079","article-title":"Genetic neurodegenerative diseases: the human illness and transgenic models","volume":"282","author":"Price","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104458_bib0145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0168-9525(98)01559-5","article-title":"Protein Precipitation: A common etiology in neurodegenerative disorders?","volume":"14","author":"Kakizuka","year":"1998","journal-title":"Trends Genet."},{"issue":"Spec No","key":"10.1016\/j.phrs.2019.104458_bib0150","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/hmg\/ddi308","article-title":"Molecular pathogenesis of Parkinson\u2019s disease","volume":"14","author":"Gandhi","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2019.104458_bib0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2000.tb05561.x","article-title":"Fatal attractions\u201d of proteins. A comprehensive hypothetical mechanism underlying alzheimer\u2019s disease and other neurodegenerative disorders","volume":"924","author":"Trojanowski","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2019.104458_bib0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.phrs.2019.104458_bib0165","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.2174\/138945012803530134","article-title":"Molecular pathology in neurodegenerative diseases","volume":"13","author":"Peden","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.phrs.2019.104458_bib0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrn3887","article-title":"Spreading of pathology in neurodegenerative diseases: a focus on human studies","volume":"16","author":"Brettschneider","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0175","first-page":"78","article-title":"Current concepts of neurodegenerative diseases","volume":"1","author":"Kovacs","year":"2014","journal-title":"EMJ Neurol"},{"key":"10.1016\/j.phrs.2019.104458_bib0180","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1134\/S0026893312020161","article-title":"Proteinopathies, neurodegenerative disorders with protein aggregation-based pathology","volume":"46","author":"Shelkovnikova","year":"2012","journal-title":"Mol. Biol."},{"key":"10.1016\/j.phrs.2019.104458_bib0185","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnins.2016.00150","article-title":"A Protein Linked to alzheimer\u2019s disease and other neurological disorders","volume":"10","author":"Vega","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103976","article-title":"The Ca(2+) sensor protein swiprosin-1\/efhd2 is present in neurites and involved in kinesin-mediated transport in neurons","volume":"9","author":"Purohit","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104458_bib0195","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/jnc.12155","article-title":"EFhd2 is a novel amyloid protein associated with Pathological Tau in alzheimer\u2019s disease","volume":"125","author":"Ferrer-Acosta","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2019.104458_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115029","article-title":"Differential co-expression between \u03b1-synuclein and ifn-\u03b3 signaling genes across development and in Parkinson\u2019s disease","volume":"9","author":"Liscovitch","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104458_bib0205","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-5956-9-59","article-title":"Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson\u2019s disease","volume":"9","author":"Diedrich","year":"2011","journal-title":"Proteome Sci."},{"key":"10.1016\/j.phrs.2019.104458_bib0210","doi-asserted-by":"crossref","first-page":"e1867","DOI":"10.1371\/journal.pone.0001867","article-title":"Formation of toxic oligomeric \u03b1-Synuclein species in living cells","volume":"3","author":"Outeiro","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104458_bib0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12868-015-0211-1","article-title":"Neuronal response in alzheimer\u2019s and Parkinson\u2019s disease: The effect of toxic proteins on intracellular pathways","volume":"16","author":"Majd","year":"2015","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0220","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009423","article-title":"Disruption of protein quality control in Parkinson\u2019s disease","volume":"2","author":"Cook","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.phrs.2019.104458_bib0225","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","article-title":"Protein aggregation in amyotrophic lateral sclerosis","volume":"125","author":"Blokhuis","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2019.104458_bib0230","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1242\/dmm.030536","article-title":"Comprehensive analysis of gene expression patterns in Friedreich\u2019s Ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers","volume":"10","author":"Napierala","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.phrs.2019.104458_bib0235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0165-0173(97)00045-3","article-title":"Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death","volume":"25","author":"Bains","year":"1997","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.phrs.2019.104458_bib0240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","article-title":"Neurodegenerative diseases and oxidative stress","volume":"58","author":"Emerit","year":"2004","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2019.104458_bib0245","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000464422","article-title":"Molecular pathogenesis of alzheimer\u2019s disease: an update","volume":"24","author":"Sanabria-Castro","year":"2017","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0250","first-page":"376","article-title":"Oxidative stress in neurodegenerative diseases","volume":"7","author":"Chen","year":"2012","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.phrs.2019.104458_bib0255","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2019.104458_bib0260","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1211\/jpp.61.03.0013","article-title":"Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of Neprilysin","volume":"61","author":"Yang","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib0265","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib0270","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","article-title":"Oxidative stress in neurodegenerative diseases","volume":"53","author":"Niedzielska","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2019.104458_bib0275","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The role of oxidative stress in neurodegenerative diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.phrs.2019.104458_bib0280","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/978-1-4684-7971-3_48","article-title":"Inciting excitotoxic cytocide among central neurons","volume":"203","author":"Olney","year":"1986","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2019.104458_bib0285","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","article-title":"Excitotoxicity: Bridge to various triggers in neurodegenerative disorders","volume":"698","author":"Mehta","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib0290","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0163-7258(98)00042-4","article-title":"The role of excitotoxicity in neurodegenerative disease: implications for therapy","volume":"81","author":"Doble","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2019.104458_bib0295","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1113\/jphysiol.2012.247981","article-title":"Selective mitochondrial Ca(2+) uptake deficit in disease endstage vulnerable motoneurons of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"591","author":"Fuchs","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2019.104458_bib0300","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fnins.2015.00469","article-title":"Chronic glutamate toxicity in neurodegenerative diseases\u2014what is the evidence?","volume":"9","author":"Lewerenz","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0305","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.sbspro.2016.02.094","article-title":"Counseling and therapy of patients with behavioural disorders using the cognitive-behavioural approach","volume":"217","author":"Shubina","year":"2016","journal-title":"Procedia - Soc. Behav. Sci."},{"key":"10.1016\/j.phrs.2019.104458_bib0310","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1542\/peds.2011-0266","article-title":"Developmental and behavioral disorders through the life span","volume":"128","author":"Stein","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.phrs.2019.104458_bib0315","first-page":"447","article-title":"The diagnosis and treatment of behavioral disorders in dementia","volume":"114","author":"Kratz","year":"2017","journal-title":"Arztebl. Int."},{"key":"10.1016\/j.phrs.2019.104458_bib0320","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1038\/nrdp.2015.20","article-title":"Attention-Deficit\/Hyperactivity disorder","volume":"1","author":"Faraone","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.phrs.2019.104458_bib0325","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","article-title":"Molecular genetics of Attention-Deficit\/Hyperactivity disorder","volume":"57","author":"Faraone","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0330","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1176\/appi.ajp.2018.18020149","article-title":"Genetic markers of ADHD-Related variations in intracranial volume","volume":"176","author":"Klein","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0335","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/jcpp.12381","article-title":"Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents","volume":"56","author":"Polanczyk","year":"2015","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0340","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neubiorev.2019.02.009","article-title":"Zebrafish models for attention deficit hyperactivity disorder (ADHD)","volume":"100","author":"Fontana","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2019.104458_bib0345","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejpn.2012.01.009","article-title":"The neurobiology and genetics of Attention-Deficit\/Hyperactivity disorder (ADHD): what every clinician should know","volume":"16","author":"Cortese","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.phrs.2019.104458_bib0350","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40263-014-0208-9","article-title":"Targeting the nicotinic cholinergic system to treat Attention-Deficit\/Hyperactivity disorder: rationale and progress to date","volume":"28","author":"Potter","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.phrs.2019.104458_bib0355","doi-asserted-by":"crossref","first-page":"69R","DOI":"10.1203\/PDR.0b013e318212b40f","article-title":"Neurobiology of attention Deficit\/Hyperactivity disorder","volume":"69","author":"Purper-Ouakil","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.phrs.2019.104458_bib0360","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnmol.2013.00019","article-title":"Autism Spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses","volume":"6","author":"Won","year":"2013","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1005113900068","article-title":"Genetic studies of autism: from the 1970s into the millennium","volume":"28","author":"Rutter","year":"2000","journal-title":"J. Abnorm. Child Psychol."},{"key":"10.1016\/j.phrs.2019.104458_bib0370","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/35103559","article-title":"Genetics of autism: complex aetiology for a heterogeneous disorder","volume":"2","author":"Folstein","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.phrs.2019.104458_bib0375","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.biopsych.2005.07.004","article-title":"Brain-derived neurotrophic factor and autoantibodies to neural antigens in Sera of Children with autistic Spectrum disorders, landau-kleffner syndrome, and epilepsy","volume":"59","author":"Connolly","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0380","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0387-7604(03)00168-2","article-title":"Serum neurotrophin concentrations in autism and mental retardation: a pilot study","volume":"26","author":"Miyazaki","year":"2004","journal-title":"Brain Dev."},{"key":"10.1016\/j.phrs.2019.104458_bib0385","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","article-title":"BDNF and synaptic plasticity, cognitive function, and dysfunction","volume":"220","author":"Lu","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib0390","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/adb.12668","article-title":"Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats","volume":"24","author":"Silva-Pe\u00f1a","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.phrs.2019.104458_bib0395","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1460-9568.1995.tb01058.x","article-title":"Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra","volume":"7","author":"Studer","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0400","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/mp.2015.27","article-title":"The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy","volume":"20","author":"Notaras","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0405","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41397-018-0041-5","article-title":"BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis","volume":"19","author":"Huang","year":"2018","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.phrs.2019.104458_bib0410","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eurpsy.2019.02.006","article-title":"High BDNF serum levels are associated to good cognitive functioning in bipolar disorder","volume":"60","author":"Mora","year":"2019","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0415","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3389\/fpsyt.2018.00776","article-title":"Brain-derived neurotrophic factor precursor in the Hippocampus Regulates both depressive and anxiety-like behaviors in rats","volume":"9","author":"Zhong","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0420","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1038\/tp.2017.95","article-title":"Altered expression of BDNF, BDNF pro-peptide and their precursor ProBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver Axis","volume":"7","author":"Yang","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0425","doi-asserted-by":"crossref","first-page":"e1079","DOI":"10.1038\/tp.2017.43","article-title":"The serum protein levels of the TPA-BDNF pathway are implicated in depression and antidepressant treatment","volume":"7","author":"Jiang","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0430","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jad.2013.03.002","article-title":"Upregulation of blood ProBDNF and its receptors in major depression","volume":"150","author":"Zhou","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2019.104458_bib0435","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1556\/2006.5.2016.010","article-title":"Serum BDNF levels in patients with gambling disorder are associated with the severity of gambling disorder and Iowa gambling task indices","volume":"5","author":"Choi","year":"2016","journal-title":"J. Behav. Addict."},{"key":"10.1016\/j.phrs.2019.104458_bib0440","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature03809","article-title":"Systematic analysis of genes required for synapse structure and function","volume":"436","author":"Sieburth","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104458_bib0445","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/bies.20843","article-title":"The role of the ubiquitin proteasome system in synapse remodeling and neurodegenerative diseases","volume":"30","author":"Ding","year":"2008","journal-title":"Bioessays"},{"key":"10.1016\/j.phrs.2019.104458_bib0450","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5483\/BMBRep.2017.50.5.038","article-title":"Synapses in neurodegenerative diseases","volume":"50","author":"Bae","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.phrs.2019.104458_bib0455","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/jnc.13713","article-title":"Synaptopathies: synaptic dysfunction in neurological disorders \u2013 a review from students to students","volume":"138","author":"Lepeta","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2019.104458_bib0460","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/nan.12014","article-title":"Mechanisms underlying synaptic vulnerability and degeneration in neurodegenerative disease","volume":"39","author":"Gillingwater","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.phrs.2019.104458_bib0465","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/mp.2016.103","article-title":"Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects","volume":"22","author":"Kim","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201553","article-title":"Striatal transcriptome of a mouse model of ADHD reveals a pattern of synaptic remodeling","volume":"13","author":"Sorokina","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104458_bib0475","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JAD-2001-3117","article-title":"Recent advances in the understanding of the role of synaptic proteins in alzheimer\u2019s disease and other neurodegenerative disorders","volume":"3","author":"Masliah","year":"2001","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104458_bib0480","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1017\/S1461145710001537","article-title":"From understanding synaptic plasticity to the development of cognitive enhancers","volume":"14","author":"Cheung","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib0485","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2016.04.005","article-title":"Synaptic pathology: a shared mechanism in neurological disease","volume":"28","author":"Henstridge","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.phrs.2019.104458_bib0490","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104458_bib0495","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00293397","article-title":"Synapse loss in anterior horn neurons in amyotrophic lateral sclerosis","volume":"88","author":"Sasaki","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2019.104458_bib0500","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","article-title":"Huntington\u2019s disease: A synaptopathy?","volume":"9","author":"Li","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2019.104458_bib0505","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00001756-199301000-00017","article-title":"Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study","volume":"4","author":"Clinton","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2019.104458_bib0510","series-title":"Neuroscience-Dealing With Frontiers","article-title":"Molecular mechanisms in synaptic plasticity","author":"Mayadevi","year":"2012"},{"key":"10.1016\/j.phrs.2019.104458_bib0515","series-title":"BDNF in Synaptic Plasticity and Memory","first-page":"135","author":"Woo","year":"2009"},{"key":"10.1016\/j.phrs.2019.104458_bib0520","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jep.2015.10.012","article-title":"Danggui-jakyak-San enhances hippocampal long-term potentiation through the ERK\/CREB\/BDNF cascade","volume":"175","author":"Yi","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib0525","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainres.2014.10.019","article-title":"Regulation of hippocampal synaptic plasticity by BDNF","volume":"1621","author":"Leal","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2019.104458_bib0530","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-015-0013-z","article-title":"Synaptic dysfunction and septin protein family members in neurodegenerative diseases","volume":"10","author":"Marttinen","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phrs.2019.104458_bib0535","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.1523\/JNEUROSCI.0924-10.2010","article-title":"Cysteine string protein-alpha prevents activity-dependent degeneration in GABAergic synapses","volume":"30","author":"Garcia-Junco-Clemente","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0540","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcdb.2015.03.008","article-title":"Cysteine string protein (CSP) and its role in preventing neurodegeneration","volume":"40","author":"Burgoyne","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2019.104458_bib0545","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-Synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2019.104458_bib0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"Alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2019.104458_bib0555","series-title":"Neurodegenerative Diseases","article-title":"Role of protein aggregation in neurodegenerative diseases","author":"Tutar","year":"2013"},{"key":"10.1016\/j.phrs.2019.104458_bib0560","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1017\/S0140525X05000075","article-title":"A dynamic developmental theory of Attention-Deficit\/Hyperactivity disorder (ADHD) predominantly Hyperactive\/Impulsive and combined subtypes","volume":"28","author":"Sagvolden","year":"2005","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.phrs.2019.104458_bib0565","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.npp.1300469","article-title":"Synaptic gating and ADHD: A biological theory of comorbidity of ADHD and anxiety","volume":"29","author":"Levy","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2019.104458_bib0570","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nn1103","article-title":"Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission","volume":"6","author":"Floresco","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0575","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1523\/JNEUROSCI.4517-09.2010","article-title":"Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior","volume":"30","author":"Blundell","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0580","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1523\/JNEUROSCI.0032-08.2008","article-title":"Synaptic imbalance, stereotypies, and impaired social interactions in mice with altered neuroligin 2 expression","volume":"28","author":"Hines","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0585","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.1146221","article-title":"A Neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice","volume":"318","author":"Tabuchi","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104458_bib0590","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1601-183X.2009.00487.x","article-title":"Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit","volume":"8","author":"Radyushkin","year":"2009","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.phrs.2019.104458_bib0595","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1073\/pnas.0711555105","article-title":"Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism","volume":"105","author":"Jamain","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.104458_bib0600","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1523\/JNEUROSCI.3032-07.2008","article-title":"Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1","volume":"28","author":"Hung","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0605","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11015","article-title":"Autistic-like behaviours and hyperactivity in mice lacking ProSAP1\/Shank2","volume":"486","author":"Schmeisser","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104458_bib0610","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nature11208","article-title":"Autistic-like social behaviour in Shank2-Mutant mice improved by restoring NMDA receptor function","volume":"486","author":"Won","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104458_bib0615","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2040-2392-1-15","article-title":"Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication","volume":"1","author":"Bozdagi","year":"2010","journal-title":"Mol. Autism"},{"key":"10.1016\/j.phrs.2019.104458_bib0620","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature09965","article-title":"Shank3 mutant mice display autistic-like behaviours and striatal dysfunction","volume":"472","author":"Peca","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104458_bib0625","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1093\/hmg\/ddr212","article-title":"Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3","volume":"20","author":"Wang","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2019.104458_bib0630","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1172\/JCI29031","article-title":"Autistic-like phenotypes in Cadps2-Knockout mice and aberrant CADPS2 splicing in autistic patients","volume":"117","author":"Sadakata","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2019.104458_bib0635","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cell.2012.08.045","article-title":"Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses","volume":"151","author":"Clement","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2019.104458_bib0640","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1750-3639.2000.tb00264.x","article-title":"Apoptotic and anti-apoptotic synaptic signaling mechanisms","volume":"10","author":"Mattson","year":"2000","journal-title":"Brain Pathol."},{"key":"10.1016\/j.phrs.2019.104458_bib0645","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/ijms18030545","article-title":"More insight into BDNF against neurodegeneration: anti-apoptosis, anti-oxidation, and suppression of autophagy","volume":"18","author":"Chen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2019.104458_bib0650","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrn3505","article-title":"BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases","volume":"14","author":"Lu","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0655","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/DBP.0b013e3181ee3833","article-title":"Emerging pharmacotherapies for neurodevelopmental disorders","volume":"31","author":"Wetmore","year":"2010","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.phrs.2019.104458_bib0660","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11910-010-0104-8","article-title":"Synapse pathology in psychiatric and neurologic disease","volume":"10","author":"van Spronsen","year":"2010","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.phrs.2019.104458_bib0665","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/j.1460-2075.1982.tb01207.x","article-title":"Purification of a new neurotrophic factor from mammalian brain","volume":"1","author":"Barde","year":"1982","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2019.104458_bib0670","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0092-8674(91)90628-C","article-title":"The TrkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and Neurotrophin-3","volume":"66","author":"Klein","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2019.104458_bib0675","article-title":"Temporal lobe epilepsy and the BDNF receptor, TrkB","author":"McNamara","year":"2012","journal-title":"Jasper\u2019s Basic Mechanisms of the Epilepsies [Internet]. 4th Edition. National Center for Biotechnology Information (US)"},{"key":"10.1016\/j.phrs.2019.104458_bib0680","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nature02617","article-title":"Structural basis of long-term potentiation in single dendritic spines","volume":"429","author":"Matsuzaki","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104458_bib0685","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neuron.2014.03.021","article-title":"Structural and molecular remodeling of dendritic spine substructures during long-term potentiation","volume":"82","author":"Bosch","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2019.104458_bib0690","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature19766","article-title":"Autocrine BDNF-TrkB signalling within a single dendritic spine","volume":"538","author":"Harward","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2019.104458_bib0695","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jep.2016.11.005","article-title":"BDNF\/PI3K\/Akt and Nogo-A\/RhoA\/ROCK signaling pathways contribute to neurorestorative effect of Houshiheisan against cerebral ischemia injury in rats","volume":"194","author":"Chang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib0700","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4331\/wjbc.v5.i4.409","article-title":"New insight in expression, transport, and secretion of brain-derived neurotrophic factor: implications in brain-related diseases","volume":"5","author":"Adachi","year":"2014","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.104458_bib0705","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1046\/j.1471-4159.2002.01085.x","article-title":"Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the Hippocampus of adult mice","volume":"82","author":"Lee","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2019.104458_bib0710","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tem.2013.10.006","article-title":"BDNF mediates adaptive brain and body responses to energetic challenges","volume":"25","author":"Marosi","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2019.104458_bib0715","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-016-0119-y","article-title":"Neurotrophic Factor Small-Molecule Mimetics Mediated Neuroregeneration and Synaptic Repair: Emerging Therapeutic Modality for Alzheimer\u2019s Disease","volume":"11","author":"Kazim","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phrs.2019.104458_bib0720","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12933-017-0505-y","article-title":"Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the src-family kinase activation","volume":"16","author":"Furukawa","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2019.104458_bib0725","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"BINDER","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.phrs.2019.104458_bib0730","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00221-009-1994-z","article-title":"BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses","volume":"199","author":"Gottmann","year":"2009","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.phrs.2019.104458_bib0735","series-title":"Post-Transcriptional Regulation by Brain-Derived Neurotrophic Factor in the Nervous System BT - Post-Transcriptional Mechanisms in Endocrine Regulation","first-page":"315","author":"Amen","year":"2016"},{"key":"10.1016\/j.phrs.2019.104458_bib0740","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/CS20160044","article-title":"Neurotrophin Signalling: Novel Insights into Mechanisms and Pathophysiology","volume":"131","author":"Mitre","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.phrs.2019.104458_bib0745","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/901082","article-title":"Serum brain-derived neurotrophic factor levels in different neurological diseases","volume":"2013","author":"Ventriglia","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.phrs.2019.104458_bib0750","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1523\/JNEUROSCI.6251-09.2010","article-title":"BDNF is associated with age-related decline in hippocampal volume","volume":"30","author":"Erickson","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0755","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2019.104458_bib0760","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0736-5748(00)00046-0","article-title":"Brain-derived neurotrophic factor and Neurotrophin-3 levels in alzheimer\u2019s disease brains","volume":"18","author":"Durany","year":"2000","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0765","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JAD-2009-1051","article-title":"Brain-derived neurotrophic factor levels in alzheimer\u2019s disease","volume":"17","author":"O\u2019Bryant","year":"2009","journal-title":"J. Alzheimers Dis."},{"issue":"Pt C","key":"10.1016\/j.phrs.2019.104458_bib0770","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.neuropharm.2013.05.043","article-title":"Pre- and postsynaptic twists in BDNF secretion and action in synaptic plasticity","volume":"76","author":"Edelmann","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2019.104458_bib0775","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1126\/science.7886457","article-title":"Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult Hippocampus","volume":"267","author":"Kang","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.phrs.2019.104458_bib0780","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0896-6273(00)80140-3","article-title":"Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice","volume":"16","author":"Patterson","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2019.104458_bib0785","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(02)01023-1","article-title":"Localized synaptic potentiation by BDNF requires local protein synthesis in the developing axon","volume":"36","author":"Zhang","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2019.104458_bib0790","first-page":"14","article-title":"Brain-derived neurotrophic factor (BDNF) as a potential mechanism of the effects of acute exercise on cognitive performance","volume":"4","author":"Piepmeier","year":"2015","journal-title":"J. Sport. Med. Allied Health Sci. Off. J. Ohio Athl. Train. Assoc."},{"key":"10.1016\/j.phrs.2019.104458_bib0795","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.92.19.8856","article-title":"Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor","volume":"92","author":"Korte","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.104458_bib0800","doi-asserted-by":"crossref","first-page":"12547","DOI":"10.1073\/pnas.93.22.12547","article-title":"Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice","volume":"93","author":"Korte","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.104458_bib0805","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0006-8993(99)01592-9","article-title":"Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats","volume":"835","author":"Mu","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2019.104458_bib0810","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hipo.10220","article-title":"Intrahippocampal administration of BDNF in adult rats affects short-term behavioral plasticity in the morris water maze and performance in the elevated plus-maze","volume":"14","author":"Cirulli","year":"2004","journal-title":"Hippocampus"},{"key":"10.1016\/j.phrs.2019.104458_bib0815","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.neuro.22.1.295","article-title":"Neurotrophins and Synaptic Plasticity","volume":"22","author":"McAllister","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0820","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brs.2009.12.003","article-title":"Brain-derived neurotrophic factor (BDNF) gene polymorphisms shape cortical plasticity in humans","volume":"3","author":"Antal","year":"2010","journal-title":"Brain Stimul."},{"key":"10.1016\/j.phrs.2019.104458_bib0825","doi-asserted-by":"crossref","first-page":"29394","DOI":"10.1074\/jbc.273.45.29394","article-title":"Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-Methyl-D-Aspartate","volume":"273","author":"Marini","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.104458_bib0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2014.12.069","article-title":"Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysis","volume":"226","author":"Ahmed","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.phrs.2019.104458_bib0835","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1601-183X.2011.00738.x","article-title":"BDNF Val66Met and cognition: All, none, or some? A meta-analysis of the genetic association","volume":"11","author":"Mandelman","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.phrs.2019.104458_bib0840","doi-asserted-by":"crossref","first-page":"e958","DOI":"10.1038\/tp.2016.214","article-title":"The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders","volume":"6","author":"Cattaneo","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0845","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00406-011-0214-6","article-title":"Association of the Brain-Derived Neurotrophic Factor Val66met Polymorphism with Magnetic Resonance Spectroscopic Markers in the Human Hippocampus: In Vivo Evidence for Effects on the Glutamate System","volume":"262","author":"Gruber","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0850","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ygeno.2007.05.004","article-title":"Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters","volume":"90","author":"Pruunsild","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.phrs.2019.104458_bib0855","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1136\/jmg.2006.044883","article-title":"Genetic variants in brain-derived neurotrophic factor associated with alzheimer\u2019s disease","volume":"44","author":"Huang","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.phrs.2019.104458_bib0860","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1479-8301.2011.00364.x","article-title":"Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in japanese patients with alzheimer\u2019s disease","volume":"11","author":"Nagata","year":"2011","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.phrs.2019.104458_bib0865","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neubiorev.2014.12.016","article-title":"A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review","volume":"51","author":"Notaras","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2019.104458_bib0870","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neubiorev.2015.04.017","article-title":"BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: a systematic review and meta-analysis","volume":"55","author":"Harrisberger","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2019.104458_bib0875","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neubiorev.2014.03.011","article-title":"The association of the BDNF Val66Met polymorphism and the hippocampal volumes in healthy humans: a joint meta-analysis of published and new data","volume":"42","author":"Harrisberger","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2019.104458_bib0880","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2016.01.030","article-title":"Val66Met BDNF polymorphism is associated with Parkinson\u2019s disease cognitive impairment","volume":"615","author":"Altmann","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2019.104458_bib0885","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1468-1331.2009.02706.x","article-title":"BDNF Val66Met polymorphism is associated with cognitive impairment in italian patients with Parkinson\u2019s disease","volume":"16","author":"Guerini","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.phrs.2019.104458_bib0890","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00415-005-0756-5","article-title":"The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson\u2019s disease","volume":"252","author":"Foltynie","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.phrs.2019.104458_bib0895","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000352033","article-title":"No association between brain-derived neurotrophic factor g196a polymorphism and clinical features of Parkinson\u2019s disease","volume":"70","author":"Svetel","year":"2013","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.phrs.2019.104458_bib0900","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2013.12.051","article-title":"BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson\u2019s disease","volume":"561","author":"Bialecka","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2019.104458_bib0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076001","article-title":"Characterizing the role of brain derived neurotrophic factor genetic variation in alzheimer\u2019s disease neurodegeneration","volume":"8","author":"Honea","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104458_bib0910","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3233\/JAD-2009-1106","article-title":"BDNF variants, premorbid educational attainment, and disease characteristics in alzheimer\u2019s disease: An exploratory study","volume":"17","author":"Zdanys","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2019.104458_bib0915","article-title":"Association of Rs6265 and Rs2030324 polymorphisms in brain-derived neurotrophic factor gene with alzheimer\u2019s disease: a meta-analysis","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104458_bib0920","article-title":"Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal alzheimer\u2019s disease: a preliminary study","volume":"9","author":"Lim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2019.104458_bib0925","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fnagi.2017.00135","article-title":"The Analysis of Two BDNF Polymorphisms G196A\/C270T in Chinese Sporadic Amyotrophic Lateral Sclerosis","volume":"9","author":"Xu","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib0930","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.mp.4001073","article-title":"A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with alzheimer\u2019s disease in patients lacking the apolipoprotein e [Straight epsilon] 4 allele","volume":"7","author":"Riemenschneider","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0935","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.mp.4000792","article-title":"A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset alzheimer\u2019s disease","volume":"6","author":"Kunugi","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib0940","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/1673-5374.198964","article-title":"Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury","volume":"12","author":"Wurzelmann","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.phrs.2019.104458_bib0945","article-title":"A phase I-II study of recombinant human brain-derived neurotrophic factor in patients with amyotrophic lateral sclerosis","volume":"38","author":"Bradley","year":"1995"},{"key":"10.1016\/j.phrs.2019.104458_bib0950","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.52.7.1427","article-title":"A controlled trial of recombinant methionyl human BDNF in ALS","volume":"52","author":"Bradley","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2019.104458_bib0955","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14660820050515197","article-title":"A phase I\/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis","volume":"1","author":"Ochs","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"10.1016\/j.phrs.2019.104458_bib0960","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4103\/1673-5374.182682","article-title":"Clinical trial perspective for adult and juvenile huntington\u2019s disease using genetically-engineered mesenchymal stem cells","volume":"11","author":"Deng","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.phrs.2019.104458_bib0965","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological and psychiatric disorders","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2019.104458_bib0970","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4161\/oxim.2.5.9498","article-title":"Plant polyphenols as dietary antioxidants in human health and disease","volume":"2","author":"Pandey","year":"2009","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2019.104458_bib0975","first-page":"A202","article-title":"Polyphenols and Brain Health","volume":"24","author":"Vauzour","year":"2017","journal-title":"OCL-Oilseeds and Fats, Crops and Lipids"},{"key":"10.1016\/j.phrs.2019.104458_bib0980","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/aje\/kwm036","article-title":"Flavonoid intake and cognitive decline over a 10-Year period","volume":"165","author":"Letenneur","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.phrs.2019.104458_bib0985","doi-asserted-by":"crossref","first-page":"32176","DOI":"10.1074\/jbc.M806154200","article-title":"Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity","volume":"283","author":"Ono","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.104458_bib0990","first-page":"23","article-title":"Modulation of neurotrophic signaling pathways by polyphenols","volume":"10","author":"Moosavi","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.phrs.2019.104458_bib0995","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/248529","article-title":"Psychiatric disorders and polyphenols: can they Be helpful in therapy?","volume":"2015","author":"Trebatick\u00e1","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2019.104458_bib1000","doi-asserted-by":"crossref","first-page":"i65","DOI":"10.1136\/bmj.i65","article-title":"Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports","volume":"352","author":"Sharma","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2019.104458_bib1005","first-page":"120","article-title":"Phytochemical, antioxidant and antidepressant evaluation of ocimum Basilicum, O. Tenuiflorum, O. Kilimandscharicum grown in India","volume":"5","author":"Tewari","year":"2015","journal-title":"J. Biol. Act. Prod. from Nat."},{"key":"10.1016\/j.phrs.2019.104458_bib1010","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1159\/000492684","article-title":"Ginsenoside Rg1 prevents chronic stress-induced depression-like behaviors and neuronal structural plasticity in rats","volume":"48","author":"Yu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.phrs.2019.104458_bib1015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2011.02.030","article-title":"Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats","volume":"493","author":"Huang","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2019.104458_bib1020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbr.2009.03.017","article-title":"Protective effects of green tea polyphenols on cognitive impairments induced by psychological stress in rats","volume":"202","author":"Chen","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2019.104458_bib1025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2011.09.007","article-title":"Green tea polyphenols produce antidepressant-like effects in adult mice","volume":"65","author":"Zhu","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2019.104458_bib1030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00787-006-0538-3","article-title":"Treatment of ADHD with French Maritime Pine Bark Extract, Pycnogenol","volume":"15","author":"Trebaticka","year":"2006","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib1035","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/10715760600824902","article-title":"Effect of polyphenolic extract, Pycnogenol, on the level of 8-Oxoguanine in children suffering from attention Deficit\/Hyperactivity disorder","volume":"40","author":"Chovanova","year":"2006","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.phrs.2019.104458_bib1040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pnpbp.2009.09.026","article-title":"Ginkgo biloba for Attention-Deficit\/Hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial","volume":"34","author":"Salehi","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2019.104458_bib1045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1024\/1422-4917\/a000309","article-title":"Ginkgo biloba extract EGb 761(R) in children with ADHD","volume":"42","author":"Uebel-von Sandersleben","year":"2014","journal-title":"Z. Kinder Jugendpsychiatr. Psychother."},{"key":"10.1016\/j.phrs.2019.104458_bib1050","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1001\/jama.299.22.2633","article-title":"Hypericum perforatum (St John\u2019s wort) for Attention-Deficit\/Hyperactivity disorder in children and adolescents: a randomized controlled trial","volume":"299","author":"Weber","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2019.104458_bib1055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/19390211.2016.1207743","article-title":"Fermented brown rice extract stimulates BDNF gene transcription in C6 glioma cells: possible connection with HO-1 expression","volume":"14","author":"Morita","year":"2017","journal-title":"J. Diet. Suppl."},{"key":"10.1016\/j.phrs.2019.104458_bib1060","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1142\/S0192415X15500391","article-title":"Beneficial effects of Polygonum multiflorum on hippocampal neuronal cells and mouse focal cerebral ischemia","volume":"43","author":"Ahn","year":"2015","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phrs.2019.104458_bib1065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.12965\/jer.1632586.293","article-title":"Aqueous extract of cordyceps alleviates cerebral ischemia-induced short-term memory impairment in gerbils","volume":"12","author":"Lee","year":"2016","journal-title":"J. Exerc. Rehabil."},{"key":"10.1016\/j.phrs.2019.104458_bib1070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/nu8110679","article-title":"Lycopersicon esculentum extract enhances cognitive function and hippocampal neurogenesis in aged mice","volume":"8","author":"Bae","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2019.104458_bib1075","article-title":"Flavonoids induce the synthesis and secretion of neurotrophic factors in cultured rat astrocytes: a signaling response mediated by estrogen receptor","volume":"2013","author":"Xu","year":"2013","journal-title":"Evid. Complement. Alternat. Med."},{"key":"10.1016\/j.phrs.2019.104458_bib1080","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1073\/pnas.92.24.11110","article-title":"Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor","volume":"92","author":"Sohrabji","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.104458_bib1085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jep.2013.08.011","article-title":"Scutellarin and Caffeic Acid Ester Fraction, Active Components of Dengzhanxixin Injection, Upregulate Neurotrophins Synthesis and Release in Hypoxia\/Reoxygenation Rat Astrocytes","volume":"150","author":"Chai","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib1090","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1073\/pnas.0913572107","article-title":"A Selective TrkB Agonist with Potent Neurotrophic Activities by 7,8-Dihydroxyflavone","volume":"107","author":"Jang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.104458_bib1095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mcn.2013.02.007","article-title":"7,8-dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways","volume":"56","author":"Tsai","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2019.104458_bib1100","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/814068","article-title":"Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review","volume":"2015","author":"Venkatesan","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.phrs.2019.104458_bib1105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.phcgj.2013.08.004","article-title":"Honokiol reverses depressive-like behavior and decrease in brain BDNF levels induced by chronic corticosterone injections in mice","volume":"5","author":"Pitta","year":"2013","journal-title":"Pharmacogn. J."},{"key":"10.1016\/j.phrs.2019.104458_bib1110","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/ptr.3706","article-title":"Antidepressant-like effect of magnolol on BDNF up-regulation and serotonergic system activity in unpredictable chronic mild stress treated rats","volume":"26","author":"Li","year":"2012","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2019.104458_bib1115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2014.04.034","article-title":"Spicatoside a enhances memory consolidation through the brain-derived neurotrophic factor in mice","volume":"572","author":"Kwon","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2019.104458_bib1120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4062\/biomolther.2015.214","article-title":"Pharmacological activities and applications of spicatoside a","volume":"24","author":"Ramalingam","year":"2016","journal-title":"Biomol. Ther. (Seoul)."},{"key":"10.1016\/j.phrs.2019.104458_bib1125","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11418-016-0970-8","article-title":"Antidepressant, antioxidant and neurotrophic properties of the standardized extract of cocos nucifera husk fiber in mice","volume":"70","author":"Lima","year":"2016","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.phrs.2019.104458_bib1130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbrc.2014.01.166","article-title":"Green tea catechins potentiate the neuritogenic action of brain-derived neurotrophic factor: role of 67-KDa laminin receptor and hydrogen peroxide","volume":"445","author":"Gundimeda","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2019.104458_bib1135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuropharm.2014.07.012","article-title":"Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice","volume":"86","author":"Patil","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2019.104458_bib1140","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1179\/1743132813Y.0000000217","article-title":"Effects of Luteolin on spatial memory, cell proliferation, and neuroblast differentiation in the hippocampal dentate gyrus in a scopolamine-induced Amnesia model","volume":"35","author":"Yoo","year":"2013","journal-title":"Neurol. Res."},{"key":"10.1016\/j.phrs.2019.104458_bib1145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12603-011-0140-3","article-title":"Effects of genistein and Daidzein on Hippocampus Neuronal cell proliferation and BDNF expression in H19-7 neural cell line","volume":"16","author":"Pan","year":"2012","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.phrs.2019.104458_bib1150","doi-asserted-by":"crossref","first-page":"16568","DOI":"10.1073\/pnas.0607822103","article-title":"Flavonoid fisetin promotes ERK-Dependent long-term potentiation and enhances memory","volume":"103","author":"Maher","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2019.104458_bib1155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11064-016-2123-6","article-title":"Anti-neuroinflammatory effects of Fucoxanthin via inhibition of Akt\/NF-KB and MAPKs\/AP-1 pathways and activation of PKA\/CREB pathway in lipopolysaccharide-activated BV-2 microglial cells","volume":"42","author":"Zhao","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phrs.2019.104458_bib1160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/md14040067","article-title":"Fucoxanthin, a Marine Carotenoid, Reverses Scopolamine-Induced Cognitive Impairments in Mice and Inhibits Acetylcholinesterase in Vitro","volume":"14","author":"Lin","year":"2016","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.phrs.2019.104458_bib1165","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1021\/acs.jnatprod.6b00371","article-title":"Nerve growth and brain-derived neurotrophic factor inducing metabolites from the mushroom hericium coralloides","volume":"79","author":"Wittstein","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phrs.2019.104458_bib1170","first-page":"2673","article-title":"Hericerin, a new pollen growth inhibitor from the mushroom hericium erinaceum","volume":"55","author":"Kimura","year":"1991","journal-title":"Agric. Biol. Chem."},{"key":"10.1016\/j.phrs.2019.104458_bib1175","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00394-017-1462-7","article-title":"Dietary eicosapentaenoic acid normalizes hippocampal Omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central Interleukin-1beta administration","volume":"57","author":"Dong","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.phrs.2019.104458_bib1180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00394-008-0703-1","article-title":"Eicosapentaenoic Acid (EPA) Increases Cell Viability and Expression of Neurotrophin Receptors in Retinoic Acid and Brain-Derived Neurotrophic Factor Differentiated SH-SY5Y Cells","volume":"47","author":"Kou","year":"2008","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.phrs.2019.104458_bib1185","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.biopha.2016.07.020","article-title":"Urtica dioica leaves modulates hippocampal smoothened-glioma associated Oncogene-1 pathway and cognitive dysfunction in chronically stressed mice","volume":"83","author":"Patel","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2019.104458_bib1190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S146114571100188X","article-title":"The antidepressant hyperforin increases the phosphorylation of CREB and the expression of TrkB in a tissue-specific manner","volume":"16","author":"Gibon","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib1195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejphar.2016.01.015","article-title":"Apigenin reverses depression-like behavior induced by chronic corticosterone treatment in mice","volume":"774","author":"Weng","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib1200","doi-asserted-by":"crossref","first-page":"9949","DOI":"10.3390\/molecules18089949","article-title":"Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an alzheimer\u2019s disease mouse model","volume":"18","author":"Zhao","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2019.104458_bib1205","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s11064-016-1881-5","article-title":"Protective effect of Silibinin on learning and memory impairment in LPS-Treated rats via ROS-BDNF-TrkB pathway","volume":"41","author":"Song","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phrs.2019.104458_bib1210","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12906-015-0746-9","article-title":"Angelica gigas ameliorate depression-like symptoms in rats following chronic corticosterone injection","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.phrs.2019.104458_bib1215","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/1061186X.2015.1077848","article-title":"Angelica sinensis reduced a\u03b2-induced memory impairment in rats","volume":"24","author":"Duan","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.phrs.2019.104458_bib1220","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jep.2016.09.023","article-title":"Antidepressant-like effects and cognitive enhancement of the total phenols extract of hemerocallis citrina baroni in chronic unpredictable mild stress rats and its related mechanism","volume":"194","author":"Xu","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2019.104458_bib1225","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12906-017-1652-0","article-title":"Withania somnifera leaf alleviates cognitive dysfunction by enhancing hippocampal plasticity in high fat diet induced obesity model","volume":"17","author":"Manchanda","year":"2017","journal-title":"BMC Complement. Altern. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819318225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819318225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:08:34Z","timestamp":1760911714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819318225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":245,"alternative-id":["S1043661819318225"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104458","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting BDNF signaling by natural products: Novel synaptic repair therapeutics for neurodegeneration and behavior disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104458"}}